Merck’s executive director, operations lead, global medical affairs and outcomes research discusses how data is helping to ...

The Health System Owned Specialty Pharmacy Alliance (HOSP) works to reduce costs and increase availability of care for ...

Jason O’Neill, author of 'The Secrets of Successful Drug Launches' and former Dendreon CEO, details how products having an insufficient relative advantage, enter the market too late, or are ...

Rob DeWig, VP of Healthcare Sales at Inmar, touches on looming DSCSA enforcement and the impact of Inmar's reconciliation tools.

Our five-year plan is to continue to do what we do really well and be that scaled, large, trusted partner that can help pharma and biopharma bring their new medicines and innovations into the market.

Novo Nordisk's shares rise as Phase III trial shows its oral Wegovy pill achieves significant weight loss, offering a new ...

In today’s Pharmaceutical Executive Daily, we explore how AI is disrupting higher education and career pathways, AllRock ...

Former CDC director Susan Monarez raises alarms about potential changes to childhood vaccine schedules, warning of increased ...

Roche strengthens its pipeline by acquiring 89bio and its promising MASH treatment, Pegozafermin, enhancing options for ...

GSK plans a $30 billion investment in US R&D and manufacturing, including $1.2 billion for advanced facilities and AI ...

One of the biggest barriers to AI scaling is the traditional divide between business and IT functions. Siloed approaches ...

Rob DeWig, Vice President of Healthcare Sales, Inmar, touches on the impact of Inmar and Premier's expanded agreement on the ...